Axl-IN-3

Axl-IN-3 is an orally bioavailable and selective AXL kinase inhibitor with an IC50 of 41.5 nM, showing minimal off-target kinase activity. It is used in cancer research to study AXL's role in tumor progression and resistance, enabling in vitro cellular assays and in vivo preclinical models for therapeutic evaluation.